Subanesthetic Esketamine in Modified ECT for Severe Depression in Adolescents: Clinical and Mechanistic Study

NCT07247968 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Esketamine
ECT
Depression
Adolescent

Interventions

DRUG: Esketamine injection group (0.25 mg/kg)
OTHER: Saline injection group (Consistent with esketamine injection volume)

Sponsor

Min Su